MYXREDLIN Trademark

Trademark Overview

On Tuesday, January 3, 2017, a trademark application was filed for MYXREDLIN with the United States Patent and Trademark Office. The USPTO has given the MYXREDLIN trademark a serial number of 87287569. The federal status of this trademark filing is REGISTERED as of Tuesday, November 5, 2019. This trademark is owned by Baxter International Inc.. The MYXREDLIN trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical products, namely, pharmaceutical preparations for the treatment of diabetes, endocrine diseases and disorders, metabolic diseases and disorders; pharmaceutical preparations containing insulin
myxredlin

General Information

Serial Number87287569
Word MarkMYXREDLIN
Filing DateTuesday, January 3, 2017
Status700 - REGISTERED
Status DateTuesday, November 5, 2019
Registration Number5903597
Registration DateTuesday, November 5, 2019
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, February 28, 2017

Trademark Statements

Goods and ServicesPharmaceutical products, namely, pharmaceutical preparations for the treatment of diabetes, endocrine diseases and disorders, metabolic diseases and disorders; pharmaceutical preparations containing insulin

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, January 12, 2017
Primary Code005
First Use Anywhere DateTuesday, July 30, 2019
First Use In Commerce DateTuesday, July 30, 2019

Trademark Owner History

Party NameBaxter International Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressDeerfield, IL 60015
Party NameBaxter International Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressDeerfield, IL 60015
Party NameBaxter International Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressDeerfield, IL 60015

Trademark Events

Event DateEvent Description
Wednesday, January 25, 2017ASSIGNED TO EXAMINER
Tuesday, February 28, 2017PUBLISHED FOR OPPOSITION
Friday, January 6, 2017NEW APPLICATION ENTERED
Thursday, January 12, 2017NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Wednesday, January 25, 2017APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, February 8, 2017NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, April 25, 2017NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Monday, October 23, 2017SOU EXTENSION 1 FILED
Monday, October 23, 2017SOU EXTENSION 1 GRANTED
Wednesday, October 25, 2017NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, April 25, 2018SOU EXTENSION 2 FILED
Wednesday, April 25, 2018SOU EXTENSION 2 GRANTED
Friday, April 27, 2018NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, February 28, 2017OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Monday, October 23, 2017SOU TEAS EXTENSION RECEIVED
Wednesday, April 25, 2018SOU TEAS EXTENSION RECEIVED
Monday, October 15, 2018SOU TEAS EXTENSION RECEIVED
Thursday, April 4, 2019SOU EXTENSION 4 FILED
Thursday, April 4, 2019SOU EXTENSION 4 GRANTED
Saturday, April 6, 2019NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, September 19, 2019TEAS STATEMENT OF USE RECEIVED
Thursday, September 19, 2019SOU TEAS EXTENSION RECEIVED
Monday, October 15, 2018SOU EXTENSION 3 FILED
Monday, October 15, 2018SOU EXTENSION 3 GRANTED
Wednesday, October 17, 2018NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, April 4, 2019SOU TEAS EXTENSION RECEIVED
Monday, September 23, 2019STATEMENT OF USE PROCESSING COMPLETE
Thursday, September 19, 2019SOU EXTENSION 5 FILED
Thursday, September 19, 2019USE AMENDMENT FILED
Monday, September 23, 2019SOU EXTENSION 5 GRANTED
Monday, September 23, 2019CASE ASSIGNED TO INTENT TO USE PARALEGAL
Tuesday, September 24, 2019NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, September 30, 2019ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Tuesday, October 1, 2019NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Tuesday, November 5, 2019REGISTERED-PRINCIPAL REGISTER
Tuesday, November 5, 2024COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED

Related Keywords

myxredlin pharmaceutical disorders diseases preparations insulin containing metabolic diabetes products namely